Vahdam India explores majority stake sale at $250-300M valuation, taps global FMCG majors
Premium D2C tea and wellness brand Vahdam India is exploring a majority stake sale at a $250-300 million valuation. Rothschild is running the process, sounding out global FMCG majors and Indian consumer firms like Mankind Pharma as potential strategic acquirers. Backers include Fireside, Sixth Sense and IIFL AMC.
Premium D2C tea and wellness brand Vahdam India is exploring a majority stake sale at a $250-300 million valuation. Rothschild is running the process, tapping global FMCG majors and Indian consumer firms as potential strategic acquirers.
Why this matters
Confirms Vahdam's earlier exploration of a majority stake sale, now with a defined $250-300M price band and named suitors including Mankind Pharma alongside MNC FMCG players.
Retail-brand activity steady with 1,688 signals over the last 90 days.